SK107595A3 - Use of anticonvulsive agents for treating aids-related neural disorders - Google Patents
Use of anticonvulsive agents for treating aids-related neural disorders Download PDFInfo
- Publication number
- SK107595A3 SK107595A3 SK1075-95A SK107595A SK107595A3 SK 107595 A3 SK107595 A3 SK 107595A3 SK 107595 A SK107595 A SK 107595A SK 107595 A3 SK107595 A3 SK 107595A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pharmaceutically acceptable
- aids
- treatment
- disorders
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9302568A FR2702148B1 (fr) | 1993-03-05 | 1993-03-05 | Application d'anticonvulsivants dans le traitement du neuro-sida. |
PCT/FR1994/000209 WO1994020110A1 (fr) | 1993-03-05 | 1994-02-25 | APPLICATION D'ANTICONVULSIVANTS COMME LA CARBAMAZEPINE ET l'OXCARBAZEPINE, DANS LE TRAITEMENT DU NEURO-SIDA |
Publications (1)
Publication Number | Publication Date |
---|---|
SK107595A3 true SK107595A3 (en) | 1996-06-05 |
Family
ID=9444690
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1075-95A SK107595A3 (en) | 1993-03-05 | 1994-02-25 | Use of anticonvulsive agents for treating aids-related neural disorders |
SK1076-95A SK279659B6 (sk) | 1993-03-05 | 1994-02-25 | Použitie riluzolu |
SK1074-95A SK107495A3 (en) | 1993-03-05 | 1994-02-25 | Use of lamotrigine for treating aids-related neural disorders |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1076-95A SK279659B6 (sk) | 1993-03-05 | 1994-02-25 | Použitie riluzolu |
SK1074-95A SK107495A3 (en) | 1993-03-05 | 1994-02-25 | Use of lamotrigine for treating aids-related neural disorders |
Country Status (23)
Country | Link |
---|---|
US (2) | US5629312A (ko) |
EP (3) | EP0687176B1 (ko) |
JP (3) | JPH08507508A (ko) |
KR (3) | KR960700721A (ko) |
AT (2) | ATE147981T1 (ko) |
AU (3) | AU6143894A (ko) |
CA (3) | CA2154571A1 (ko) |
CZ (3) | CZ284423B6 (ko) |
DE (2) | DE69427344T2 (ko) |
DK (2) | DK0687177T3 (ko) |
ES (2) | ES2157252T3 (ko) |
FR (1) | FR2702148B1 (ko) |
GR (2) | GR3022356T3 (ko) |
HU (3) | HUT73434A (ko) |
IL (3) | IL108845A0 (ko) |
NO (3) | NO953372L (ko) |
PL (3) | PL310474A1 (ko) |
PT (1) | PT687176E (ko) |
RU (1) | RU2157205C2 (ko) |
SK (3) | SK107595A3 (ko) |
UA (1) | UA41355C2 (ko) |
WO (3) | WO1994020103A1 (ko) |
ZA (2) | ZA941530B (ko) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866597A (en) * | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
GB9424766D0 (en) * | 1994-12-07 | 1995-02-08 | Wellcome Found | Pharmaceutical composition |
GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
DE19603984A1 (de) * | 1996-02-05 | 1997-08-07 | Bayer Ag | Granulate von Triazinen |
US20020022056A1 (en) | 1997-02-14 | 2002-02-21 | Burkhard Schlutermann | Oxacarbazepine film-coated tablets |
CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
US5922746A (en) * | 1997-03-27 | 1999-07-13 | Allergan | Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
GB9721497D0 (en) * | 1997-10-09 | 1997-12-10 | Ciba Geigy Ag | Organic compounds |
FR2774592B1 (fr) * | 1998-02-06 | 2000-03-17 | Rhone Poulenc Rorer Sa | Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet |
FR2774908B1 (fr) * | 1998-02-17 | 2000-06-23 | Centre Nat Rech Scient | Utilisation d'inhibiteur de la liberation du glutamate dans le traitement de l'ischemie retinienne |
FR2787028B1 (fr) * | 1998-12-15 | 2002-10-18 | Aventis Pharma Sa | Utilisation du riluzole dans le traitement des traumatismes acoustiques |
AU4424500A (en) * | 1999-04-29 | 2000-11-17 | Centre National De La Recherche Scientifique (C.N.R.S.) | A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping |
US7479498B2 (en) | 1999-08-23 | 2009-01-20 | Phoenix Biosciences, Inc. | Treatments for viral infections |
GB9925962D0 (en) * | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
FR2801217B1 (fr) * | 1999-11-24 | 2002-12-06 | Aventis Pharma Sa | Association de riluzole et de gabapentine et son utilisation comme medicament |
GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
US6207179B1 (en) * | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
CA2471666C (en) | 2004-06-18 | 2009-10-13 | Apotex Pharmachem Inc. | An improved process for the preparation of oxcarbazepine and related intermediates |
EP1874353A1 (en) * | 2005-04-05 | 2008-01-09 | Yale University | Glutamate modulating agents in the treatment of mental disorders |
US20060252745A1 (en) * | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
FR2910811B1 (fr) * | 2007-01-03 | 2009-07-10 | Ass Pour Le Dev De La Biothera | Utilisation du riluzole et de ses derives pour fabriquer de nouveaux medicaments |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
FR2957077B1 (fr) * | 2010-03-02 | 2012-04-13 | Univ Dauvergne Clermont I | Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux |
KR102580378B1 (ko) * | 2014-11-21 | 2023-09-19 | 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. | 릴루졸의 설하 제제 |
CA3209488A1 (en) * | 2021-02-24 | 2022-09-01 | Jacob BONTA | Foaming evaporator coil cleaner |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492258A1 (fr) * | 1980-10-17 | 1982-04-23 | Pharmindustrie | Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole |
US4431641A (en) * | 1980-10-17 | 1984-02-14 | Ciba-Geigy Corporation | Pharmaceutical compositions having antiepileptic and antineuralgic action |
GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
US4826860A (en) * | 1987-03-16 | 1989-05-02 | Warner-Lambert Company | Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents |
US4918090A (en) * | 1988-01-25 | 1990-04-17 | Warner-Lambert Company | Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents |
EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
JPH07308499A (ja) * | 1994-05-20 | 1995-11-28 | Brother Ind Ltd | 衣類乾燥機 |
-
1993
- 1993-03-05 FR FR9302568A patent/FR2702148B1/fr not_active Expired - Lifetime
-
1994
- 1994-02-25 PL PL94310474A patent/PL310474A1/xx unknown
- 1994-02-25 CA CA002154571A patent/CA2154571A1/fr not_active Abandoned
- 1994-02-25 PL PL94310475A patent/PL310475A1/xx unknown
- 1994-02-25 SK SK1075-95A patent/SK107595A3/sk unknown
- 1994-02-25 CZ CZ952261A patent/CZ284423B6/cs unknown
- 1994-02-25 JP JP6519648A patent/JPH08507508A/ja active Pending
- 1994-02-25 JP JP6519649A patent/JPH08507509A/ja active Pending
- 1994-02-25 PL PL94310476A patent/PL310476A1/xx unknown
- 1994-02-25 EP EP94908374A patent/EP0687176B1/fr not_active Expired - Lifetime
- 1994-02-25 SK SK1076-95A patent/SK279659B6/sk not_active IP Right Cessation
- 1994-02-25 PT PT94908374T patent/PT687176E/pt unknown
- 1994-02-25 AT AT94908376T patent/ATE147981T1/de active
- 1994-02-25 EP EP94908376A patent/EP0687177B1/fr not_active Expired - Lifetime
- 1994-02-25 HU HU9502583A patent/HUT73434A/hu unknown
- 1994-02-25 AU AU61438/94A patent/AU6143894A/en not_active Abandoned
- 1994-02-25 SK SK1074-95A patent/SK107495A3/sk unknown
- 1994-02-25 HU HU9502584A patent/HU9502584D0/hu unknown
- 1994-02-25 WO PCT/FR1994/000208 patent/WO1994020103A1/fr active IP Right Grant
- 1994-02-25 DE DE69427344T patent/DE69427344T2/de not_active Expired - Lifetime
- 1994-02-25 DK DK94908376.0T patent/DK0687177T3/da active
- 1994-02-25 AU AU61439/94A patent/AU675119B2/en not_active Ceased
- 1994-02-25 HU HU9502585A patent/HU217132B/hu not_active IP Right Cessation
- 1994-02-25 CZ CZ952259A patent/CZ285339B6/cs not_active IP Right Cessation
- 1994-02-25 CA CA002154573A patent/CA2154573A1/fr not_active Abandoned
- 1994-02-25 EP EP94908375A patent/EP0687179A1/fr not_active Withdrawn
- 1994-02-25 DK DK94908374T patent/DK0687176T3/da active
- 1994-02-25 WO PCT/FR1994/000209 patent/WO1994020110A1/fr not_active Application Discontinuation
- 1994-02-25 ES ES94908374T patent/ES2157252T3/es not_active Expired - Lifetime
- 1994-02-25 AU AU61437/94A patent/AU675118B2/en not_active Ceased
- 1994-02-25 UA UA95083996A patent/UA41355C2/uk unknown
- 1994-02-25 ES ES94908376T patent/ES2096455T3/es not_active Expired - Lifetime
- 1994-02-25 CA CA002154572A patent/CA2154572C/fr not_active Expired - Fee Related
- 1994-02-25 JP JP51964794A patent/JP3578174B2/ja not_active Expired - Fee Related
- 1994-02-25 CZ CZ952260A patent/CZ226095A3/cs unknown
- 1994-02-25 DE DE69401577T patent/DE69401577T2/de not_active Expired - Fee Related
- 1994-02-25 AT AT94908374T patent/ATE201597T1/de active
- 1994-02-25 US US08/530,253 patent/US5629312A/en not_active Expired - Fee Related
- 1994-02-25 KR KR1019950703734A patent/KR960700721A/ko not_active Application Discontinuation
- 1994-02-25 KR KR1019950703733A patent/KR960700723A/ko not_active Application Discontinuation
- 1994-02-25 KR KR1019950703732A patent/KR100318168B1/ko not_active IP Right Cessation
- 1994-02-25 RU RU95121731/14A patent/RU2157205C2/ru not_active IP Right Cessation
- 1994-02-25 WO PCT/FR1994/000210 patent/WO1994020108A1/fr active IP Right Grant
- 1994-03-03 IL IL10884594A patent/IL108845A0/xx unknown
- 1994-03-03 IL IL10884694A patent/IL108846A0/xx not_active IP Right Cessation
- 1994-03-03 IL IL108844A patent/IL108844A/en not_active IP Right Cessation
- 1994-03-04 ZA ZA941530A patent/ZA941530B/xx unknown
- 1994-03-04 ZA ZA941525A patent/ZA941525B/xx unknown
-
1995
- 1995-02-28 US US08/396,106 patent/US5624945A/en not_active Expired - Lifetime
- 1995-08-28 NO NO953372A patent/NO953372L/no unknown
- 1995-08-28 NO NO953370A patent/NO307687B1/no not_active IP Right Cessation
- 1995-08-28 NO NO953371A patent/NO953371L/no unknown
-
1997
- 1997-01-23 GR GR960402768T patent/GR3022356T3/el unknown
-
2001
- 2001-05-31 GR GR20010400060T patent/GR3035957T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK107595A3 (en) | Use of anticonvulsive agents for treating aids-related neural disorders | |
DE60103556T3 (de) | Zusammensetzungen zur behandlung von fettleibigkeit, welche antagonisten der cb1-rezeptoren und sibutramine enthalten | |
SK86695A3 (en) | Anticonvulsive agents for treatment of parkinson`s disease and parkinsonian syndromes | |
NO317178B1 (no) | Anvendelse av (+) norcisaprid for fremstilling av medikamenter samt farmasoytisk preparat og enhetsdoseform omfattende forbindelsen | |
CA2248873A1 (en) | Method for treating pain | |
DE60307049T2 (de) | Verwendung von Piperazin- Phenothiazin- Derivaten zur Herstellung eines Arzneimittels mit neuroprotektiven und/oder neurotropischen Wirkungen auf das ZNS und/oder PNS | |
US20010051653A1 (en) | Method for improving disturbancies of activities of daily living after stroke | |
DE60034249T2 (de) | Kombination enthaltend cyamemazine und ein atypisches neuroleptikum | |
CZ289344B6 (cs) | Léčivo umoľňující pacientovi, aby sám omezil konzumaci alkoholu | |
DE102004031538A1 (de) | Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit | |
DE3432974A1 (de) | Arzneimittel zur prophylaxe oder therapie der negativen shizophreniesymtome bei menschen | |
US5656647A (en) | Application of riluzole for promoting restoration following radiation | |
JPH0449231A (ja) | 新規な分化誘導促進剤 | |
DE2362685A1 (de) | Neue 3,9-bis-basische ester von 7hbenz- eckige klammer auf de eckige klammer zu -anthracen-7-on, verfahren zu ihrer herstellung sowie diese enthaltende pharmazeutische praeparate | |
DE10039610A1 (de) | Azepinoindol-Derivate, deren Herstellung und Anwendung | |
WO2003061654A1 (de) | Pramipexol zur behandlung von hiv demenz |